• A patient information leaflet on Hirsutism is available at the British Association of Dermatologists 
  • For some women with facial hirsutism topical eflornithine offers advantages over oral co-cyprindiol (Preparations for acne and rosacea) as it avoids the risks associated with systemic therapies.

EFLORNITHINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

(S) (Vaniqa®) cream 11·5%

Dosage:

Apply thinly twice daily. Eflornithine is much more effective where physical methods of hair removal are being used simultaneously. In the absence of improvement after treatment for 4 months, discontinue eflornithine.

Editorial Information

Document Id: F140